|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01N 65/00 | |
| A61K 36/47 | |||
| A61K 36/38 |
| (11) | Patento numeris | 2529626 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12182318.1 |
| Europos patento paraiškos padavimo data | 2007-04-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-12-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-11-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 797075 P | 2006-05-01 | US |
| (72) |
Quart, Barry, US
|
| (73) |
Napo Pharmaceuticals, Inc.,
201 Mission Street, Suite 2375, San Francisco, CA 94105,
US
|
| (54) | Compositions and methods for treating or preventing colon cancer |
| Compositions and methods for treating or preventing colon cancer |